- Q702 is a novel, orally available triple kinase inhibitor that selectively targets Axl, Mer, and CSF1R - A phase…
RMIT University adopts HPE GreenLake to meet increasing demand for online learning and growth of its essential research HPE GreenLake…
MACAU, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (�Studio City� or the �Company�), a…
-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates…
WALL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access…
Revenue up 34% year-over-year to $49.9M, GAAP operating income of $0.9 million and Adjusted EBITDA reached $4.0 million PETAH TIKVA,…
Zai Lab obtains exclusive rights to develop and commercialize KarXT in Greater China Karuna to receive upfront cash payment of…
-- Broad Product Pipeline Expands Both Vertically and Horizontally with Three New Potential First-in-Class or Best-in-Class Medicines -- Company to…
12.4% Year-Over-Year Revenue Growth 56.4% Year-Over-Year Subscription Revenue Growth $16.5 million in Net Cash Provided by Operating Activities Leading to…
DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company,…